Now the company has the official Turkish Health Authority accreditation it can manufacture calcium carbonate as an API.
The site called Omya is working in line with the strictest quality requirements and industry-leading GMP-compliant manufacturing practices set out in the good manufacturing practice guide.
Together with its manufacturing sites in the USA and France, this is for Omya now the third fully certified plant supplying the pharma, nutraceutical, and food industries.
The plant is also compliant with the international ISO standards of basic quality, environment and work safety.
The company’s mineral particles are processed in Turkey from high-purity marble stone in accordance with the most stringent sustainability and quality standards, and with a very low environmental footprint. In the plant, ultrapure and white calcium carbonate is processed to various morphologies, thus offering a broad range of products with multiple functionalities.
The company says the resulting mineral ingredients designated for the pharmaceutical industry under the brand name Omyapure offer numerous benefits for finished products, facilitate production processes and increase nutritional profiles. As such, Omyapure can be used in antacid products as well as osteoporosis treatments.
To successfully operate the plant while preserving and protecting its delicate surroundings, Omya says it is highly considerate of the environment in all areas of its activity.
Stefan Lander, vice president consumer goods, at Omya, said: “Having our third plant now certified for the production of pharmaceutical actives and expanding our offerings from Kemalpasa in Turkey will help us serve our global customers with natural and highly functional minerals, while maintaining a focus on economic and ecological efficiency, which is fully aligned with Omya’s purpose of making life better through our passion for minerals and chemistry.”